(Q43612688)

English

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect (English)

1 reference

Europe PubMed Central

25 November 2017

tetrahydrocannabinol

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

object named as

F Noble

2

0 references

author name string

O Valverde

1

1 reference

Europe PubMed Central

25 November 2017

F Beslot

3

1 reference

Europe PubMed Central

25 November 2017

V Daugé

4

1 reference

Europe PubMed Central

25 November 2017

M C Fournié-Zaluski

5

1 reference

Europe PubMed Central

25 November 2017

B P Roques

6

1 reference

Europe PubMed Central

25 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

25 November 2017

European Journal of Neuroscience

1 reference

Europe PubMed Central

25 November 2017

13

1 reference

Europe PubMed Central

25 November 2017

1816-1824

1 reference

Europe PubMed Central

25 November 2017

9

1 reference

Europe PubMed Central

25 November 2017

The effects of cannabinoids on the brain

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

A comparison of some pharmacological actions of morphine and ?9-tetrahydrocannabinol in the mouse

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Increased levels of Met-enkephalin-like material in the CSF of anaesthetized cats after tooth pulp stimulation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

delta-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

delta 9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Cannabinoid receptors and their endogenous agonists.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Effects of apomorphine and diazepam on a quickly learned conditioned suppression in rats.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Drug abuse: hedonic homeostatic dysregulation

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Self-administration of Δ9-tetrahydrocannabinol by rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01558.X

21 January 2018

Identifiers

10.1046/J.0953-816X.2001.01558.X

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43612688&oldid=2112698415"